Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 142
Filter
1.
Pflugers Arch ; 470(5): 779-786, 2018 05.
Article in English | MEDLINE | ID: mdl-29164310

ABSTRACT

Cold exposure is directly related to skin conditions, such as frostbite. This is due to the cold exposure inducing a vasoconstriction to reduce cutaneous blood flow and protect against heat loss. However, a long-term constriction will cause ischaemia and potentially irreversible damage. We have developed techniques to elucidate the mechanisms of the vascular cold response. We focused on two ligand-gated transient receptor potential (TRP) channels, namely, the established "cold sensors" TRP ankyrin 1 (TRPA1) and TRP melastin (TRPM8). We used the anaesthetised mouse and measured cutaneous blood flow by laser speckle imaging. Two cold treatments were used. A generalised cold treatment was achieved through whole paw water immersion (10 °C for 5 min) and a localised cold treatment that will be potentially easier to translate to human studies was carried out on the mouse paw with a copper cold probe (0.85-cm diameter). The results show that TRPA1 and TRPM8 can each act as a vascular cold sensor to mediate the vasoconstrictor component of whole paw cooling as expected from our previous research. However, the local cooling-induced responses were only blocked when the TRPA1 and TRPM8 antagonists were given simultaneously. This suggests that this localised cold probe response requires both functional TRPA1 and TRPM8.


Subject(s)
Microvessels/metabolism , Skin/blood supply , TRPA1 Cation Channel/metabolism , TRPM Cation Channels/metabolism , Thermosensing , Animals , Cold Temperature , Male , Mice , Microvessels/physiology , Vasoconstriction
2.
Psychopharmacology (Berl) ; 234(15): 2289-2297, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28551713

ABSTRACT

RATIONALE: Biased attention towards drug-related cues and reduced inhibitory control over the regulation of drug-intake characterize drug addiction. The noradrenaline system has been critically implicated in both attentional and response inhibitory processes and is directly affected by drugs such as cocaine. OBJECTIVES: We examined the potentially beneficial effects of the noradrenaline reuptake inhibitor atomoxetine in improving cognitive control during two tasks that used cocaine- and non-cocaine-related stimuli. METHODS: A double-blind, placebo-controlled, and cross-over psycho-pharmacological design was employed. A single oral dose of atomoxetine (40 mg) was administered to 28 cocaine-dependent individuals (CDIs) and 28 healthy controls. All participants performed a pictorial attentional bias task involving both cocaine- and non-cocaine-related pictures as well as a verbal go/no-go task composed of cocaine- and food-related words. RESULTS: As expected, CDIs showed attentional bias to cocaine-related cues whilst controls did not. More importantly, however, atomoxetine, relative to placebo, significantly attenuated attentional bias in CDIs (F 26 = 6.73, P = 0.01). During the go/no-go task, there was a treatment × trial × group interaction, although this finding only showed a trend towards statistical significance (F 26 = 3.38, P = 0.07). CONCLUSIONS: Our findings suggest that atomoxetine reduces attentional bias to drug-related cues in CDIs. This may result from atomoxetine's modulation of the balance between tonic/phasic activity in the locus coeruleus and the possibly parallel enhancement of noradrenergic neurotransmission within the prefrontal cortex. Studying how cognitive enhancers such as atomoxetine influence key neurocognitive indices in cocaine addiction may help to develop reliable biomarkers for patient stratification in future clinical trials.


Subject(s)
Adrenergic Uptake Inhibitors/administration & dosage , Atomoxetine Hydrochloride/administration & dosage , Attentional Bias/drug effects , Cocaine-Related Disorders/psychology , Cues , Administration, Oral , Adrenergic Uptake Inhibitors/blood , Adult , Atomoxetine Hydrochloride/blood , Attention/drug effects , Attention/physiology , Attentional Bias/physiology , Cocaine-Related Disorders/blood , Cocaine-Related Disorders/drug therapy , Cross-Over Studies , Double-Blind Method , Female , Humans , Male , Middle Aged , Photic Stimulation/methods , Psychomotor Performance/drug effects , Psychomotor Performance/physiology , Treatment Outcome
3.
Curr Res Transl Med ; 64(4): 195-201, 2016.
Article in English | MEDLINE | ID: mdl-27939458

ABSTRACT

This review highlights the progress from the initial finding of neurogenic inflammation up to the most recent development in the field of sensory nerves research, focusing on their roles in the microvasculature and the skin. Recent discovery of Transient Receptor Potential (TRP) channels highlight their important roles in detecting a range of environmental stimuli, including chemical and temperature. This provides us novel mechanisms for driving neurogenic inflammation upstream of neuropeptide release in addition to promising potential therapeutic targets in various diseases, including pain, itching and skin inflammation.


Subject(s)
Neurogenic Inflammation/physiopathology , Sensory Receptor Cells/physiology , Skin/innervation , Animals , Cell Communication , Dermatitis/physiopathology , Humans , Irritants/toxicity , Keratinocytes/physiology , Microcirculation/physiology , Nerve Tissue Proteins/physiology , Neuralgia/physiopathology , Neuropeptides/physiology , Nociception/physiology , Nociceptors/physiology , Physical Stimulation , Pruritus/physiopathology , Skin/blood supply , Transient Receptor Potential Channels/physiology , Vasodilation/physiology
4.
Physiol Rev ; 94(4): 1099-142, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25287861

ABSTRACT

Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide. Discovered 30 years ago, it is produced as a consequence of alternative RNA processing of the calcitonin gene. CGRP has two major forms (α and ß). It belongs to a group of peptides that all act on an unusual receptor family. These receptors consist of calcitonin receptor-like receptor (CLR) linked to an essential receptor activity modifying protein (RAMP) that is necessary for full functionality. CGRP is a highly potent vasodilator and, partly as a consequence, possesses protective mechanisms that are important for physiological and pathological conditions involving the cardiovascular system and wound healing. CGRP is primarily released from sensory nerves and thus is implicated in pain pathways. The proven ability of CGRP antagonists to alleviate migraine has been of most interest in terms of drug development, and knowledge to date concerning this potential therapeutic area is discussed. Other areas covered, where there is less information known on CGRP, include arthritis, skin conditions, diabetes, and obesity. It is concluded that CGRP is an important peptide in mammalian biology, but it is too early at present to know if new medicines for disease treatment will emerge from our knowledge concerning this molecule.


Subject(s)
Calcitonin Gene-Related Peptide/genetics , Calcitonin Gene-Related Peptide/metabolism , Animals , Calcitonin Gene-Related Peptide/chemistry , Cardiovascular Physiological Phenomena , Humans , Pain/metabolism , Receptors, Calcitonin Gene-Related Peptide/metabolism , Signal Transduction
5.
Neurobiol Dis ; 71: 245-59, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25151644

ABSTRACT

Vascular endothelial growth factor-A (VEGF-A) is best known as a key regulator of the formation of new blood vessels. Neutralization of VEGF-A with anti-VEGF therapy e.g. bevacizumab, can be painful, and this is hypothesized to result from a loss of VEGF-A-mediated neuroprotection. The multiple vegf-a gene products consist of two alternatively spliced families, typified by VEGF-A165a and VEGF-A165b (both contain 165 amino acids), both of which are neuroprotective. Under pathological conditions, such as in inflammation and cancer, the pro-angiogenic VEGF-A165a is upregulated and predominates over the VEGF-A165b isoform. We show here that in rats and mice VEGF-A165a and VEGF-A165b have opposing effects on pain, and that blocking the proximal splicing event - leading to the preferential expression of VEGF-A165b over VEGF165a - prevents pain in vivo. VEGF-A165a sensitizes peripheral nociceptive neurons through actions on VEGFR2 and a TRPV1-dependent mechanism, thus enhancing nociceptive signaling. VEGF-A165b blocks the effect of VEGF-A165a. After nerve injury, the endogenous balance of VEGF-A isoforms switches to greater expression of VEGF-Axxxa compared to VEGF-Axxxb, through an SRPK1-dependent pre-mRNA splicing mechanism. Pharmacological inhibition of SRPK1 after traumatic nerve injury selectively reduced VEGF-Axxxa expression and reversed associated neuropathic pain. Exogenous VEGF-A165b also ameliorated neuropathic pain. We conclude that the relative levels of alternatively spliced VEGF-A isoforms are critical for pain modulation under both normal conditions and in sensory neuropathy. Altering VEGF-Axxxa/VEGF-Axxxb balance by targeting alternative RNA splicing may be a new analgesic strategy.


Subject(s)
Antibodies/therapeutic use , DNA, Recombinant/genetics , Neuralgia/metabolism , Neuralgia/therapy , RNA, Messenger/metabolism , Vascular Endothelial Growth Factor A , Animals , Antibodies/pharmacology , Benzofurans , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Ganglia, Spinal/cytology , Hyperalgesia/metabolism , Male , Mice , Mice, Transgenic , Neural Conduction/genetics , Pain Measurement , Pain Threshold/physiology , Quinolines , RNA, Messenger/genetics , Rats , Rats, Wistar , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/metabolism , TRPV Cation Channels/deficiency , TRPV Cation Channels/genetics , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/immunology , Vascular Endothelial Growth Factor A/metabolism
6.
Neuroimage ; 101: 531-46, 2014 Nov 01.
Article in English | MEDLINE | ID: mdl-24993894

ABSTRACT

To date, most functional Magnetic Resonance Imaging (fMRI) studies have assumed that the functional connectivity (FC) between time series from distinct brain regions is constant across time. However, recently, there has been an increased interest in quantifying possible dynamic changes in FC during fMRI experiments, as it is thought that this may provide insight into the fundamental workings of brain networks. In this work we focus on the specific problem of estimating the dynamic behavior of pair-wise correlations between time courses extracted from two different regions of the brain. We critique the commonly used sliding-window technique, and discuss some alternative methods used to model volatility in the finance literature that could also prove to be useful in the neuroimaging setting. In particular, we focus on the Dynamic Conditional Correlation (DCC) model, which provides a model-based approach towards estimating dynamic correlations. We investigate the properties of several techniques in a series of simulation studies and find that DCC achieves the best overall balance between sensitivity and specificity in detecting dynamic changes in correlations. We also investigate its scalability beyond the bivariate case to demonstrate its utility for studying dynamic correlations between more than two brain regions. Finally, we illustrate its performance in an application to test-retest resting state fMRI data.


Subject(s)
Connectome/methods , Data Interpretation, Statistical , Image Processing, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Models, Statistical , Adult , Computer Simulation , Female , Humans , Male , Rest
7.
Theor Appl Genet ; 126(8): 2149-61, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23689747

ABSTRACT

Powdery mildew (PM) is a very important disease of cucumber (Cucumis sativus L.). Resistant cultivars have been deployed in production for a long time, but the genetic mechanisms of PM resistance in cucumber are not well understood. A 3-year QTL mapping study of PM resistance was conducted with 132 F2:3 families derived from two cucumber inbred lines WI 2757 (resistant) and True Lemon (susceptible). A genetic map covering 610.4 cM in seven linkage groups was developed with 240 SSR marker loci. Multiple QTL mapping analysis of molecular marker data and disease index of the hypocotyl, cotyledon and true leaf for responses to PM inoculation identified six genomic regions in four chromosomes harboring QTL for PM resistance in WI 2757. Among the six QTL, pm1.1 and pm1.2 in chromosome 1 conferred leaf resistance. Minor QTL pm3.1 (chromosome 3) and pm4.1 (chromosome 4) contributed to disease susceptibility. The two major QTL, pm5.1 and pm5.2 were located in an interval of ~40 cM in chromosome 5 with each explaining 21.0-74.5 % phenotypic variations. Data presented herein support two recessively inherited, linked major QTL in chromosome 5 plus minor QTL in other chromosomes that control the PM resistance in WI 2757. The QTL pm5.2 for hypocotyl resistance plays the most important role in host resistance. Multiple observations in the same year revealed the importance of scoring time in the detection of PM resistance QTL. Results of this study provided new insights into phenotypic and genetic mechanisms of powdery mildew resistance in cucumber.


Subject(s)
Cucumis sativus/genetics , Disease Resistance/genetics , Mycoses/immunology , Plant Diseases/immunology , Ascomycota , Chromosome Mapping , Chromosomes, Plant/genetics , Cucumis sativus/immunology , Genes, Plant/genetics , Genetic Linkage , Quantitative Trait Loci/genetics
9.
Gastroenterol. latinoam ; 24(1): 9-13, 2013. tab
Article in Spanish | LILACS | ID: lil-763432

ABSTRACT

Introduction: Celiac disease (CD) is an autoimmune disorder that affects the gastrointestinal tract and other systems like the neuropsychiatric system, where depression is the most frequent disease. Objectives: To determine the prevalence of depression in adult celiac patients and relate these results with the adherence to a gluten-free diet. Materials and Methods: Descriptive cross-sectional study, with +18-year-old patients diagnosed with CD, confirmed with biopsy. 123 subjects from Fundación Convivir and from Instituto de Diagnóstico Gastroenterológico answered Beck Depression Inventory II (BDI-II) vía e-mail, which consists of 21 questions on personal aspects of their life; and also a survey on general aspects generales. A result of > 20 points was considered depression. Results: Average age was 38.9 years, 82.9 percent female. 17.1 percent (21 cases) present with depression according to BDI-II score. 62.6 percent adhere to the diet and 10.4 percent present depression; on the other hand, of 37.4 percent that are non-adherent, 28.3 percent present this disease. The association between both variables is statistically significant (p < 0.014). Discussion: High prevalence of depression was determined in CD patients compared to 9 percent, corresponding to the countries global figure. Most of them showed previous history of depressive disease. Adequate adherence to a gluten-free diet is associated to lower prevalence of depression.


Introducción: La enfermedad celíaca (EC) es una patología autoinmune que afecta al aparato gastrointestinal y a otros sistemas como el neuro-psiquátrico, área en la que la depresión es la patología más frecuente. Objetivos: Determinar la prevalencia de depresión en pacientes adultos con EC y relacionar resultados con la adherencia o no a una dieta libre de gluten. Materiales y Métodos: Estudio descriptivo de corte transversal que incluyó a pacientes de 18 años o más, con diagnóstico de EC confirmado por biopsia. Se aplicó vía correo electrónico el Inventario de Depresión de Beck II (BDI-II) que consta de 21 preguntas sobre aspectos de su vida personal; y una encuesta de antecedentes generales a 123 sujetos provenientes de la Fundación Convivir y del Instituto de Diagnóstico Gastroenterológico. Se consideró depresión si el puntaje es > 20 puntos. Resultados: La edad promedio fue de 38,9 años y el 82,9 por ciento eran mujeres. El 17,1 por ciento (21 casos) presentan depresión según la escala de BDI-II. El 62,6 por ciento son adherentes a la dieta y presentan depresión el 10,4 por ciento; en cambio del 37,4 por ciento que no son adherentes, el 28,3 por ciento presenta esta patología. La asociación entre ambas variables es estadísticamente significativa (p < 0,014). Discusión: Se determinó una alta prevalencia de depresión en pacientes con EC en comparación con 9 por ciento que corresponde a la cifra global del país. La mayoría de ellos presentaban antecedentes previos de enfermedad depresiva. Una adecuada adherencia a la dieta libre de gluten se asocia a una menor frecuencia de depresión.


Subject(s)
Humans , Male , Female , Adolescent , Young Adult , Middle Aged , Celiac Disease/epidemiology , Depressive Disorder/epidemiology , Cross-Sectional Studies , Diet, Gluten-Free , Epidemiology, Descriptive , Celiac Disease/diet therapy , Celiac Disease/psychology , Patient Compliance , Prevalence , Surveys and Questionnaires
10.
Acta Physiol (Oxf) ; 203(1): 87-98, 2011 Sep.
Article in English | MEDLINE | ID: mdl-20950342

ABSTRACT

Transient receptor potential anykrin 1 (TRPA1) is a member of the TRP superfamily, representing the sole member of the TRPA subfamily. It has many identified endogenous and exogenous agonists, comprising largely of chemical irritants and products of oxidative stress. Classically located on sensory neurone endings, TRPA1 has developed a strong presence in pain and inflammatory studies, where it is now becoming an intriguing clinical drug target. TRPA1 is increasingly recognized in a growing number of neuronal and non-neuronal locations with expanding expression and activity profiles providing evidence of a role for TRPA1 in other systems. Interest in discovering the pharmacological and functional roles of TRPA1 is increasing and diversifying into many areas. Historically, compounds now known as TRPA1 agonists have demonstrated cardiovascular activity, modulating activities in both the heart and the vasculature. Now TRPA1 has been identified as the receptor via which these compounds can act, these studies are being revisited and expanded on using current techniques. It is therefore timely to review the current knowledge of TRPA1 receptor presence and activities of relevance to the cardiovascular system, summarizing findings to date and identifying potential areas for future investigation.


Subject(s)
Calcium Channels/metabolism , Calcium Channels/pharmacology , Cardiovascular Physiological Phenomena , Cardiovascular System/metabolism , Nerve Tissue Proteins/metabolism , Nerve Tissue Proteins/pharmacology , Transient Receptor Potential Channels/metabolism , Transient Receptor Potential Channels/pharmacology , Animals , Cardiovascular Physiological Phenomena/drug effects , Cardiovascular System/drug effects , Humans , TRPA1 Cation Channel
11.
Stress ; 12(3): 259-67, 2009 May.
Article in English | MEDLINE | ID: mdl-19051122

ABSTRACT

Calcitonin gene-related peptide (CGRP) is involved in a variety of stress responses and plays a pivotal role in stress-induced suppression of the GnRH pulse generator in the rat. Intracerebroventricular administration of CGRP suppresses luteinizing hormone (LH) pulses and increases Fos expression within the medial preoptic area (mPOA) and paraventricular nucleus (PVN). The aims of the present study were to investigate whether the mPOA or PVN are sites of action for CGRP-induced suppression of LH pulses and whether lipopolysaccharide (LPS), restraint or insulin-induced hypoglycaemia, stressors known to suppress LH pulses, affect mRNA expression for CGRP and its receptor subunits (calcitonin receptor-like receptor (CL) and RAMP-1) in the mPOA and PVN. Micro-infusion of CGRP (50, 250 or 500 pmol) into the mPOA, but not the PVN, dose-dependently suppressed LH pulse frequency. LPS, restraint and hypoglycaemia suppressed RAMP-1 mRNA, but not CL or CGRP mRNA expression in the mPOA. In the PVN, all three stressors suppressed CL mRNA expression, but only LPS or restraint suppressed RAMP-1 mRNA, and CGRP mRNA was unaffected. These results provide evidence that, unlike the PVN, the mPOA might play an important role in the inhibitory effect of CGRP on pulsatile LH secretion. Additionally, CGRP receptor function may be involved in this brain region in stress-induced suppression of the GnRH pulse generator.


Subject(s)
Calcitonin Gene-Related Peptide/physiology , Luteinizing Hormone/metabolism , Preoptic Area/physiology , Stress, Psychological/physiopathology , Animals , Calcitonin Gene-Related Peptide/pharmacology , Female , Lipopolysaccharides/pharmacology , Paraventricular Hypothalamic Nucleus/drug effects , Paraventricular Hypothalamic Nucleus/physiology , Preoptic Area/drug effects , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, Calcitonin Gene-Related Peptide/biosynthesis , Restraint, Physical
12.
Stress ; 11(4): 312-9, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18574791

ABSTRACT

Corticotrophin-releasing hormone (CRH) plays a pivotal role in the suppression of the gonadotrophin-releasing hormone (GRH) pulse generator in response to stress and intracerebroventricular (i.c.v.) administration of calcitonin gene-related peptide (CGRP). We have previously shown both CRH receptor subtypes, CRH-R1 and CRH-R2, are involved in the stress-induced suppression of LH pulses. The aims of the present study were to examine the role of CRH-R1 and CRH-R2 in CGRP-induced suppression of LH pulses, and to investigate the effects of CGRP on CRH expression in the paraventricular nucleus (PVN) and central nucleus of the amygdala (CeA), which have prominent CRH neurone populations that receive dense CGRP innervations. The suppression of LH pulses by CGRP (1.5 microg i.c.v.) was completely prevented by intravenous administration of the CRH-R1 antagonist SSR125543Q (7.5 mg/rat i.v., 30 min before CGRP), but was not affected by the CRH-R2 antagonist, astressin(2)-B (100 microg i.c.v., 10 min before CGRP). CGRP increased the CRH mRNA expression in PVN and CeA. These results provide evidence of a role for CRH-R1 in mediating the suppressive effects of CGRP on pulsatile LH secretion in the female rat, and additionally raise the possibility of an involvement of PVN and CeA CRH neuronal populations in this suppression.


Subject(s)
Calcitonin Gene-Related Peptide/pharmacology , Corticotropin-Releasing Hormone/antagonists & inhibitors , Luteinizing Hormone/metabolism , Receptors, Corticotropin-Releasing Hormone/physiology , Amygdala/drug effects , Amygdala/physiology , Animals , Female , Injections, Intraventricular , Paraventricular Hypothalamic Nucleus/drug effects , Paraventricular Hypothalamic Nucleus/physiology , Peptide Fragments/pharmacology , Peptides, Cyclic/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors , Thiazoles/pharmacology
13.
Br J Pharmacol ; 154(5): 1094-103, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18454165

ABSTRACT

BACKGROUND AND PURPOSE: We investigated the mechanisms underlying the pruritogenic response induced by trypsin in mice, to assess the relevance of neurogenic inflammation components in this response. EXPERIMENTAL APPROACH: Itching was induced by an intradermal injection of trypsin in the mouse neck. The animals were observed for 40 min and their scratching behaviour was quantified. KEY RESULTS: Trypsin-induced itching was blocked by the lima bean trypsin inhibitor, the selective proteinase-activated receptor-2 (PAR-2) antagonist FSLLRY and PAR-2 receptor desensitization. An important involvement of mast cells was observed, as chronic pretreatment with the mast cell degranulator compound 48/80 or the mast cell stabilizer disodium cromoglycate prevented scratching. Also, trypsin response was inhibited by the selective COX-2 inhibitor celecoxib and by the selective kinin B2 (FR173657) and B1 (SSR240612) receptor antagonists. Moreover, an essential role for the mediators of neurogenic inflammation was established, as the selective NK1 (FK888), NK3 (SR142801) and calcitonin gene-related peptide (CGRP(8-37) fragment) receptor antagonists inhibited trypsin-induced itching. Similarly, blockade of transient receptor potential vanilloid 1 (TRPV1) receptors by the selective TRPV1 receptor antagonist SB366791, or by genetic deletion of TRPV1 receptor reduced this behaviour in mice. C-fibre desensitization showed a very similar result. CONCLUSIONS AND IMPLICATIONS: Trypsin intradermal injection proved to be a reproducible model for the study of itching and the involvement of PAR-2 receptors. Also, trypsin-induced itching seems to be widely dependent on neurogenic inflammation, with a role for TRPV1 receptors. In addition, several other mediators located in the sensory nerves and skin also seem to contribute to this process.


Subject(s)
Behavior, Animal , Neurogenic Inflammation/prevention & control , Pruritus/prevention & control , Signal Transduction , Anilides/pharmacology , Animals , Antipruritics/pharmacology , Behavior, Animal/drug effects , Bradykinin Receptor Antagonists , Calcitonin Gene-Related Peptide/pharmacology , Calcitonin Gene-Related Peptide Receptor Antagonists , Celecoxib , Cell Degranulation/drug effects , Cinnamates/pharmacology , Cromolyn Sodium/pharmacology , Cyclooxygenase 2/metabolism , Cyclooxygenase 2 Inhibitors/pharmacology , Dioxoles/pharmacology , Disease Models, Animal , Injections, Intradermal , Male , Mast Cells/drug effects , Mice , Mice, Knockout , Nerve Fibers, Unmyelinated/metabolism , Neurogenic Inflammation/chemically induced , Neurogenic Inflammation/metabolism , Oligopeptides/pharmacology , Peptide Fragments/pharmacology , Plant Proteins/pharmacology , Pruritus/chemically induced , Pruritus/metabolism , Pyrazoles/pharmacology , Quinolines/pharmacology , Receptor, PAR-2/antagonists & inhibitors , Receptor, PAR-2/metabolism , Receptors, Bradykinin/metabolism , Receptors, Calcitonin Gene-Related Peptide/metabolism , Reproducibility of Results , Signal Transduction/drug effects , Sulfonamides/pharmacology , TRPV Cation Channels/antagonists & inhibitors , TRPV Cation Channels/genetics , TRPV Cation Channels/metabolism , Trypsin/administration & dosage , p-Methoxy-N-methylphenethylamine/pharmacology
14.
Endocrinology ; 148(12): 5984-90, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17872370

ABSTRACT

Early life exposure to immunological challenge has programming effects on the adult hypothalamo-pituitary-adrenocortical axis stress responsivity, and stress is known to suppress GnRH pulse generator activity, especially LH pulses. We investigated the effects of neonatal exposure to endotoxin on stress-induced suppression of pulsatile LH secretion and the involvement of corticotropin-releasing factor (CRF) receptor mechanisms in adult rats. Pups at 3 and 5 d of age were administered lipopolysaccharide (LPS, 50 microg/kg, ip). At 12 wk of age, they were ovariectomized and implanted with sc 17beta-estradiol capsules and i.v. cannulas. Blood samples (25 microl) were collected every 5 min for 5 h for LH measurement. After 2 h of sampling, rats were given LPS (25 microg/kg, iv). CRF and CRF-R1 and CRF-R2 receptor mRNA was determined by RT-PCR in medial preoptic area (mPOA) micropunches collected at 3 h after LPS administration. There was no difference in basal LH pulse frequency between neonatal LPS- and neonatal saline-treated controls. However, neonatal endotoxin-treated rats exhibited a significantly greater LPS stress-induced suppression of LH pulse frequency. Basal mPOA CRF-R1 expression was unchanged in neonatal LPS- and neonatal saline-treated rats. However, CRF-R1 expression was significantly increased in response to LPS stress in neonatal LPS-treated animals but not in neonatal saline-treated controls. CRF and CRF-R2 expression was unchanged in all treatment groups. These data demonstrate that exposure to bacterial endotoxin in early neonatal life programs long-term sensitization of the GnRH pulse generator to the inhibitory influence of stress in adulthood, an effect that might involve up-regulation of CRF-R1 expression in the mPOA.


Subject(s)
Lipopolysaccharides/pharmacology , Luteinizing Hormone/metabolism , Receptors, Corticotropin-Releasing Hormone/genetics , Animals , Animals, Newborn , Female , Gene Expression/drug effects , Gonadotropin-Releasing Hormone/blood , Gonadotropin-Releasing Hormone/metabolism , Luteinizing Hormone/blood , Pregnancy , Preoptic Area/drug effects , Preoptic Area/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Radioimmunoassay , Rats , Reverse Transcriptase Polymerase Chain Reaction , Time Factors
15.
Inflamm Res ; 56(11): 459-67, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18224287

ABSTRACT

OBJECTIVE: The participation of sensory neurons and transient receptor potential vanilloid 1 (TRPV1) receptors in phorbol 12-myristate 13-acetate (PMA)-induced nerve-sensitizing effect was examined. MATERIALS AND METHODS: PMA dissolved in acetone and acetone were applied to the ears of TRPV1 receptor knockout and wild-type mice. Different groups of animals received ibuprofen, anti-interleukin-1 beta (IL-1beta) antibody, resiniferatoxin (RTX) or capsaicin pretreatment. Ear thickness, myeloperoxidase activity and IL-1beta content of the ears were determined. Histological evaluation was performed. RESULTS: PMA exerted potentiating action on contralateral acetone-induced ear oedema, which was inhibited by ibuprofen, topical capsaicin desensitization of the acetone-treated ear as well as by systemic RTX pretreatment. Neither the lack of TRPV1 receptors nor anti-IL-1beta antibody prevented sensitizing effect. CONCLUSIONS: The TRPV1 receptor-independent potentiating action of PMA on contralateral acetone-induced ear oedema is mediated via capsaicin-sensitive afferents and prostanoids are involved. IL-1beta is not essential in this process.


Subject(s)
Acetone/pharmacology , Ear/pathology , Edema/immunology , TRPV Cation Channels/physiology , Acetone/administration & dosage , Administration, Cutaneous , Afferent Pathways , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antibodies/pharmacology , Capsaicin/pharmacology , Diterpenes/pharmacology , Drug Synergism , Ear/innervation , Edema/chemically induced , Edema/pathology , Ibuprofen/pharmacology , Interleukin-1beta/immunology , Interleukin-1beta/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Peroxidase/metabolism , Sensory Receptor Cells/physiopathology , TRPV Cation Channels/genetics , Tetradecanoylphorbol Acetate/administration & dosage , Tetradecanoylphorbol Acetate/pharmacology
16.
J Neuroendocrinol ; 18(8): 602-10, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16867181

ABSTRACT

Corticotrophin-releasing factor (CRF) plays a pivotal role in stress-induced suppression of the gonadotrophin-releasing hormone pulse generator. We have previously shown that type 2 CRF receptors (CRF(2)) mediate restraint stress-induced suppression of luteinising hormone (LH) pulses in the rat. The present study aimed: (i) to determine whether type 1 CRF receptors (CRF(1)) are also involved in this response to restraint and (ii) to investigate the differential involvement of CRF(1) and CRF(2) in the suppression of LH pulses in response to the metabolic perturbation of insulin-induced hypoglycemia and the innate immunological challenge of lipopolysaccharide (LPS). Ovariectomised rats with oestrogen replacement were implanted with intracerebroventricular (i.c.v.) and intravenous (i.v.) cannulae. Blood samples (25 microl) were collected every 5 min for 5 h for LH measurement. After 2 h of controlled blood sampling, rats were either exposed to restraint (1 h) or injected intravenously with insulin (0.25 IU/kg) or LPS (5 microg/kg). All three stressors suppressed LH pulses. The CRF(1) antagonist SSR125543Q (11.5 micromol/rat i.v., 30 min before stressor) blocked the inhibitory response to restraint, but not hypoglycaemia or LPS stress. In addition to its effect on restraint, the CRF(2) antagonist astressin(2)-B (28 nmol/rat i.c.v., 10 min before insulin or LPS) blocked hypoglycaemia or LPS stress-induced suppression of LH pulses. These results suggest that hypoglycaemia and LPS stress-induced LH suppression involves activation of CRF(2) while restraint stress-induced inhibition of LH pulses involves both CRF(1) and CRF(2).


Subject(s)
Gonadotropin-Releasing Hormone/physiology , Hypoglycemia/blood , Luteinizing Hormone/blood , Receptors, Corticotropin-Releasing Hormone/physiology , Stress, Physiological/blood , Animals , Female , Lipopolysaccharides/immunology , Luteinizing Hormone/metabolism , Periodicity , Rats , Rats, Wistar , Restraint, Physical , Stress, Physiological/immunology , Stress, Psychological/blood
17.
Lancet ; 368(9530): 157-69, 2006 Jul 08.
Article in English | MEDLINE | ID: mdl-16829300

ABSTRACT

Multiple organ failure is a major threat to the survival of patients with sepsis and systemic inflammation. In the UK and in the USA, mortality rates are currently comparable with and projected to exceed those from myocardial infarction. The immune system combats microbial infections but, in severe sepsis, its untoward activity seems to contribute to organ dysfunction. In this Review we propose that an inappropriate activation and positioning of neutrophils within the microvasculature contributes to the pathological manifestations of multiple organ failure. We further suggest that targeting neutrophils and their interactions with blood vessel walls could be a worthwhile therapeutic strategy for sepsis.


Subject(s)
Multiple Organ Failure , Neutrophils/physiology , Sepsis , Humans , Multiple Organ Failure/etiology , Multiple Organ Failure/immunology , Multiple Organ Failure/physiopathology , Neutrophils/immunology , Sepsis/blood , Sepsis/immunology , Sepsis/physiopathology
18.
Circ Res ; 98(2): 262-70, 2006 Feb 03.
Article in English | MEDLINE | ID: mdl-16373602

ABSTRACT

Adrenomedullin (AM) levels are elevated in cardiovascular disease, but little is known of the role of specific receptor components. AM acts via the calcitonin receptor-like receptor (CLR) interacting with a receptor-activity-modifying protein (RAMP). The AM1 receptor is composed of CLR and RAMP2, and the calcitonin gene-related peptide (CGRP) receptor of CLR and RAMP1, as determined by molecular and cell-based analysis. This study examines the relevance of RAMP2 in vivo. Transgenic (TG) mice that overexpress RAMP2 in smooth muscle were generated. The role of RAMP2 in the regulation of blood pressure and in vascular function was investigated. Basal blood pressure, acute angiotensin II-raised blood pressure, and cardiovascular properties were similar in wild-type (WT) and TG mice. However, the hypotensive effect of IV AM, unlike CGRP, was enhanced in TG mice (P<0.05), whereas a negative inotropic action was excluded by left-ventricular pressure-volume analysis. In aorta relaxation studies, TG vessels responded in a more sensitive manner to AM (EC50, 8.0+/-1.5 nmol/L) than WT (EC50, 17.9+/-3.6 nmol/L). These responses were attenuated by the AM receptor antagonist, AM(22-52), such that residual responses were identical in all mice. Remaining relaxations were further inhibited by CGRP receptor antagonists, although neither affected AM responses when given alone. Mesenteric and cutaneous resistance vessels were also more sensitive to AM in TG than WT mice. Thus RAMP2 plays a key role in the sensitivity and potency of AM-induced hypotensive responses via the AM1 receptor, providing evidence that this receptor is a selective target for novel therapeutic approaches.


Subject(s)
Blood Pressure/drug effects , Intracellular Signaling Peptides and Proteins/physiology , Membrane Proteins/physiology , Peptides/pharmacology , Vasodilation/drug effects , Adrenomedullin , Animals , Calcitonin Gene-Related Peptide/pharmacology , Calcitonin Receptor-Like Protein , Dose-Response Relationship, Drug , Female , In Vitro Techniques , Male , Mice , Mice, Transgenic , Nitric Oxide/physiology , Receptor Activity-Modifying Protein 1 , Receptor Activity-Modifying Protein 2 , Receptor Activity-Modifying Proteins , Receptors, Adrenomedullin , Receptors, Calcitonin/physiology , Receptors, Calcitonin Gene-Related Peptide/drug effects , Receptors, Calcitonin Gene-Related Peptide/physiology , Receptors, Peptide/physiology
19.
J Chromatogr A ; 1095(1-2): 81-8, 2005 Nov 18.
Article in English | MEDLINE | ID: mdl-16275286

ABSTRACT

Soil from a redundant coke oven site has been examined by extraction of soluble materials using 1-methyl-2-pyrrolidinone (NMP) followed by size exclusion chromatography (SEC) of the extracted material. The extracted material was found to closely resemble a high temperature coal tar pitch. Standard humic and fulvic acids were also examined since these materials are very soluble in NMP and would be extracted with pitch if present in the soil. Humic substances derived from peat samples and NMP-extracts of peats were also examined. The results show that the humic and fulvic substances were not extracted directly by NMP from peats. They were extracted using caustic soda solution and were different from the peat extracts in NMP. These results indicate that humic and fulvic acids were soluble in NMP in the protonated polyelectrolyte form but not in the original native polyelectrolyte form. The extraction of soil using NMP followed by SEC appears to be a promising method for identifying contamination by coal-based industries.


Subject(s)
Benzopyrans/analysis , Chromatography, Gel/methods , Coal Tar/analysis , Humic Substances/analysis , Soil Pollutants/analysis , Soil/analysis , Pyrrolidinones/chemistry , Solvents , Spectrometry, Fluorescence
20.
J Neuroendocrinol ; 17(9): 541-4, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16101891

ABSTRACT

Recent evidence has shown calcitonin gene-related peptide (CGRP) to be a key mediator of stress-induced suppression of the gonadotrophin-releasing hormone (GnRH) pulse generator, although little is known about the neural pathways involved. In the present study, we investigated the potential direct action of CGRP on GnRH neurones using GT1-7 cells, an established GnRH cell line. First, we detected expression of the CGRP receptor subunits, calcitonin receptor-like receptor and receptor activity-modifying protein-1 in the GT1-7 cells by reverse transcriptase-polymerase chain reaction. Second, we have shown that CGRP inhibits GnRH mRNA expression in the GT1-7 cells, which was effectively reversed by the CGRP receptor antagonist, CGRP8-37. These results suggest that CGRP down regulates expression of GnRH mRNA, via CGRP receptors in the GT1-7 cell, thus implying that a potential direct action of CGRP may mediate a suppressive effect on the GnRH neural network.


Subject(s)
Calcitonin Gene-Related Peptide/pharmacology , Gonadotropin-Releasing Hormone/biosynthesis , Neurons/metabolism , RNA, Messenger/biosynthesis , Cell Line , Depression, Chemical , Gene Expression/drug effects , Gonadotropin-Releasing Hormone/genetics , Humans , Intracellular Signaling Peptides and Proteins , Membrane Proteins/biosynthesis , Neurons/drug effects , Receptor Activity-Modifying Proteins , Receptors, Calcitonin Gene-Related Peptide/drug effects , Receptors, Calcitonin Gene-Related Peptide/genetics , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...